WELL Health Technologies Corp. (WHTCF)
OTCMKTS · Delayed Price · Currency is USD
2.937
-0.073 (-2.43%)
Jan 8, 2026, 9:30 AM EST
WELL Health Technologies Revenue
WELL Health Technologies had revenue of 364.60M CAD in the quarter ending September 30, 2025, with 55.72% growth. This brings the company's revenue in the last twelve months to 1.21B, up 31.92% year-over-year. In the year 2024, WELL Health Technologies had annual revenue of 919.69M with 18.51% growth.
Revenue (ttm)
1.21B CAD
Revenue Growth
+31.92%
P/S Ratio
0.84
Revenue / Employee
802.02K CAD
Employees
1,507
Market Cap
750.99M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 919.69M | 143.63M | 18.51% |
| Dec 31, 2023 | 776.05M | 206.92M | 36.36% |
| Dec 31, 2022 | 569.14M | 266.81M | 88.25% |
| Dec 31, 2021 | 302.32M | 252.08M | 501.76% |
| Dec 31, 2020 | 50.24M | 17.43M | 53.12% |
| Dec 31, 2019 | 32.81M | 22.25M | 210.71% |
| Dec 31, 2018 | 10.56M | - | - |
| Oct 31, 2017 | - | - | - |
| Oct 31, 2016 | 284.62K | - | - |
| Oct 31, 2015 | - | - | - |
| Oct 31, 2014 | - | - | - |
| Oct 31, 2013 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |
WELL Health Technologies News
- 6 days ago - WELL Health Technologies: The Serial Acquirer That Will Dominate 2026 - Seeking Alpha
- 4 weeks ago - WELL Subsidiary WELLSTAR Technologies Closes $62M Financing to Support Its Pre-Spinout Growth Strategy - Business Wire
- 7 weeks ago - WashTec AG (WHTAF) Analyst/Investor Day Transcript - Seeking Alpha
- 7 weeks ago - WELL Health Reports Strong Organic Growth, Major Advances in Clinic Digitization, and Rapid Progress on New Primary Care Patient Openings - Business Wire
- 2 months ago - WELL Health Provides Corporate Update on WELLSTAR Reflecting Organic and Inorganic Growth Wins - Business Wire
- 2 months ago - WashTec AG (WBO:WSU) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus
- 2 months ago - Q3 2025 Washtec AG Earnings Call Transcript - GuruFocus
- 2 months ago - WELL Health Technologies Corp. (WELL:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha